# Neyssa Marina

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/neyssa-marina/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,064 |
| Field | Sarcoma Diagnosis and Treatment |
| h-index | 65 |
| i10-index | 139 |
| Last Known Institution | Coherus BioSciences (United States) |
| OpenAlex ID | https://openalex.org/A5085873078 |
| ORCID iD | 0000-0002-7195-8887 |
| Works | 295 |

## Researcher papers

- [Chronic Health Conditions in Adult Survivors of Childhood Cancer](https://scholariq.org/papers/chronic-health-conditions-in-adult-survivors-of-childhood-cancer/)
- [Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort](https://scholariq.org/papers/survival-and-prognosis-with-osteosarcoma-outcomes-in-more-than-2000-patients-in/)
- [Development of Risk-Based Guidelines for Pediatric Cancer Survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines From the Children's Oncology Group Late Effects Committee and Nursing Discipline](https://scholariq.org/papers/development-of-risk-based-guidelines-for-pediatric-cancer-survivors-the-children/)
- [Biology and Therapeutic Advances for Pediatric Osteosarcoma](https://scholariq.org/papers/biology-and-therapeutic-advances-for-pediatric-osteosarcoma/)
- [Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial](https://scholariq.org/papers/comparison-of-mapie-versus-map-in-patients-with-a-poor-response-to-preoperative/)
- [Genome-Informed Targeted Therapy for Osteosarcoma](https://scholariq.org/papers/genome-informed-targeted-therapy-for-osteosarcoma/)
- [Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial](https://scholariq.org/papers/methotrexate-doxorubicin-and-cisplatin-map-plus-maintenance-pegylated-interferon/)
- [Abnormalities of the Thyroid in Survivors of Hodgkin’s Disease: Data from the Childhood Cancer Survivor Study<sup>1</sup>](https://scholariq.org/papers/abnormalities-of-the-thyroid-in-survivors-of-hodgkin-s-disease-data-from-the/)
- [EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment](https://scholariq.org/papers/euramos-1-an-international-randomised-study-for-osteosarcoma-results-from-pre/)
- [Dose-Intensified Compared With Standard Chemotherapy for Nonmetastatic Ewing Sarcoma Family of Tumors: A Children's Oncology Group Study](https://scholariq.org/papers/dose-intensified-compared-with-standard-chemotherapy-for-nonmetastatic-ewing/)
- [Genome-wide association study identifies two susceptibility loci for osteosarcoma](https://scholariq.org/papers/genome-wide-association-study-identifies-two-susceptibility-loci-for/)
- [Impact of location of inpatient cancer care on patients with Ewing sarcoma and osteosarcoma—A population‐based study](https://scholariq.org/papers/impact-of-location-of-inpatient-cancer-care-on-patients-with-ewing-sarcoma-and/)

## Researcher topics

- [Sarcoma Diagnosis and Treatment](https://scholariq.org/topics/sarcoma-diagnosis-and-treatment/)
- [Childhood Cancer Survivors' Quality of Life](https://scholariq.org/topics/childhood-cancer-survivors-quality-of-life/)
- [Neuroblastoma Research and Treatments](https://scholariq.org/topics/neuroblastoma-research-and-treatments/)
- [Testicular diseases and treatments](https://scholariq.org/topics/testicular-diseases-and-treatments/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)

## Researcher university

- [Coherus BioSciences (United States)](https://scholariq.org/institutions/coherus-biosciences-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.